anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Source Note

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,355
Current window 46,921-46,950
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all
18 30 60

Component

46,921-46,950 of 110,355

filter-aware
175
Uses expert testimony to frame the company's situation as dire.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
176
Uses expert testimony to undermine management credibility and highlight operational failures.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
177
The slide uses expert testimony to undermine the credibility of the CEO and the company's strategic direction.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
178
Uses expert testimony to undermine the investment thesis of a turnaround.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
179
The slide uses expert testimony to undermine the credibility of the CEO and the company's growth prospects.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
180
Uses expert consultation quotes to undermine the credibility of the CEO's turnaround narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
181
The slide uses a direct quote from a 'Longtime C-level executive' to undermine investor confidence in the CEO.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
182
The slide uses a testimonial to debunk the 'take-out' thesis, framing the company as a 'one-trick pony' in a 'price war'.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
183
Uses expert testimony to debunk market optimism regarding M&A.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
184
The slide uses expert testimony to debunk the bull case of a potential acquisition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
185
The slide uses direct quotes from industry experts to undermine the investment thesis of Nevro, specifically targeting the idea of a potential acquisition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
186
The slide uses a 'villain' framing by characterizing Nevro's technology as 'gimmicky' and 'one-size fits all' while highlighting a competitor's superior clinical outcomes.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
187
Uses OpenPayments data to link Nevro's top paid KOLs to the Saluda clinical trial authorship.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
188
The slide uses expert quotes to build a narrative of competitive vulnerability for Nevro.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
189
The slide uses highlighted text to emphasize key negative sentiment regarding Nevro's customer loyalty and future market position.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
190
The slide uses a 'villain critique' style by highlighting the defection of key opinion leaders (KOLs) from the subject company to a competitor.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
191
The slide uses quotes from industry experts to allege unethical behavior and kickbacks in the neuromodulation market.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
192
Includes a direct testimonial quote highlighted in yellow.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
193
Uses quotes from industry participants to validate the thesis of unsustainable pricing pressure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
194
The slide uses expert testimony to contradict potential growth narratives, specifically highlighting a $5,000 price erosion per device.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
195
Uses expert testimony to frame the company's pricing strategy as a terminal failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
196
Uses expert testimony to frame the company's business model as structurally flawed due to customer leverage.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
197
The slide uses highlighted quotes from an ex-executive to frame the company's pricing strategy as a 'stupid move' that destroyed value.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
198
The slide uses a 'villain critique' approach by framing the company's growth story as 'false' and 'misguided' while citing external regulatory bodies to validate the bearish thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
199
The slide uses a series of quotes and summaries from medical and state-level reviews to undermine the company's value proposition.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
200
Uses highlighted text to emphasize key negative sentiment from KOLs.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
201
Uses direct quotes from 'high volume implanters' to build credibility for the bearish thesis.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
202
Uses direct quotes from high-volume implanters to contradict the market growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
203
The slide uses a series of testimonials to undermine the company's growth narrative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit
204
The slide uses direct quotes from former employees to support the thesis of fraudulent market growth reporting.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller 1 hit